Yi-Luen Shen M.D. is graduated from Taipei Medical University, Taiwan, R.O.C. He completed residentship and fellowship in pulmonology at Taipei Veterans General Hospital and subsequently went to Asian University Hospital to pursue an academic career and work as an intensive care physician. His primary research interest focuses on airway disease, COVID-19, and thoracic oncology.

Dawei Yang, MD
Pulmonary Attending, Zhongshan Hospital, Fudan University, Shanghai, China.
Associate Researcher, Department of Medicine, Division of Pulmonary, Critical care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.
Vice Director, Shanghai Engineer & Technology Research Center of Internet of Things for Respiratory Medicine
Vice-director of the department of Medical Internet of Things (MIOT) of Shanghai Respiratory Research Institution
Secretary of Chinese Alliance Against Lung Cancer
Research Interests: Medical Internet of Things (MIOT), Convergence of Opinion on Recommendations and Evidence (CORE), Lung Cancer, Lung Fibrosis
Dr. Yang is dedicated to the early diagnosis of lung cancer and relevant studies, with special interests in the management of pulmonary nodules and validation of diagnostic biomarker panels based on MIOT, CORE, and radiomics artificial intelligence (AI) platform. He is a member of the IASLC Prevention, Screening & Early Detection Committee. Since 2011, he has published 17 SCI research articles and 9 as the first author, including which on Am J Respir Crit Care (2013), Can Lett (2015, 2020), Cancer (2015, 2018, 2020), and Dev Cell (2020), etc. As a presenter for oral or poster presentations in ATS, WCLC, APSR, ISRD a couple of times. He is one of the peer reviewers for international journals, such as J Cell Mol Med, J Transl Med, etc, and managing editor of Clinical eHealth. He has host one National Natural Science Foundation of China (NSFC81500078), and three nationwide multicenter clinical studies as sub-PI (NCT01928836, NCT02726633, and NCT02693496). Dr. Yang worked in Prof. Charles A. Powell’s lab at Mount Sinai Hospital, focusing on TGFBR2 signaling pathway cross-talking with endothelial cells in lung adenocarcinoma invasion and angiogenesis as well as the animal model and image study of lung fibrosis. Dr. Yang joined the Prof. Chunxue Bai team to help develop the nCapp and PNapp cloud plus terminal platform to assist international physician diagnosis and treatment of COVID-19 and lung cancer.